Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains

/in
Wang, S., Chan, KW., Wei, D. et al. Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains. Nat Commun 15, 4301 (2024). https://doi.org/10.1038/s41467-024-48514-8 [Article]